Sign in
4/A

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-22-000782

Options or other derivatives

  • Chief Executive Officer acquired 6,722 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Young David · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-31 Grant or award : show line 1 in the form Restricted Stock Units +6,722 22,780 D
Loading xslF345X03/doc1.xml…